BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 17080748)

  • 1. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome in adolescents.
    Kent SC; Legro RS
    Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome.
    Legro RS
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1367-78. PubMed ID: 12510993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for and treatment of polycystic ovary syndrome in teenagers.
    Salmi DJ; Zisser HC; Jovanovic L
    Exp Biol Med (Maywood); 2004 May; 229(5):369-77. PubMed ID: 15096648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent polycystic ovary syndrome.
    Connor EL
    Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of PCOS in adolescence.
    Warren-Ulanch J; Arslanian S
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):311-30. PubMed ID: 16772160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E; Kiapekou E; Loutradis D
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and metformin in polycystic ovary syndrome.
    Ben-Haroush A; Yogev Y; Fisch B
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
    Otto-Buczkowska E; Grzyb K; Jainta N
    Pediatr Endocrinol Diabetes Metab; 2018; 24(1):40-44. PubMed ID: 30083660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Puberty and polycystic ovary syndrome.
    Witchel SF
    Mol Cell Endocrinol; 2006 Jul; 254-255():146-53. PubMed ID: 16750596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.
    Sawathiparnich P; Weerakulwattana L; Santiprabhob J; Likitmaskul S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S33-7. PubMed ID: 16856423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiometabolic features of polycystic ovary syndrome.
    Hoffman LK; Ehrmann DA
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and the long-term consequences of polycystic ovary syndrome.
    Bhathena RK
    J Obstet Gynaecol; 2011; 31(2):105-10. PubMed ID: 21281021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.